Literature DB >> 12174214

A quick and simple method for detecting subjects with abnormal genetic background in case-control samples.

D Curtis1, B V North, H M D Gurling, E Blaveri, P C Sham.   

Abstract

It is important that case-control samples be drawn from a genetically homogeneous population in order to avoid artefactual false positive results and to enhance power to detect disease mutations and markers in linkage disequilibrium with them. Tests which simply compare overall marker allele frequencies between cases and controls will fail to identify a relatively small number of subjects drawn from a different genetic background who could usefully be discarded from the sample. Such subjects can be identified using multilocus tests, but previously described tests have been unnecessarily complex and cumbersome for this simple application. We describe a straightforward test, implemented in the CHECKHET program, which uses a measure of genetic difference and permutation procedures to rapidly identify such subjects using genotypes from multiple unlinked markers. It seems to perform reasonably well on simulated data, and with real data appears to identify two abnormal subjects within a case-control sample. We recommend that such tests be routinely applied to case-control samples once sufficient numbers of markers have been genotyped within them.

Mesh:

Year:  2002        PMID: 12174214     DOI: 10.1017/S0003480002001094

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  7 in total

1.  Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study.

Authors:  Alexander P Reiner; Elad Ziv; Denise L Lind; Caroline M Nievergelt; Nicholas J Schork; Steven R Cummings; Angie Phong; Esteban González Burchard; Tamara B Harris; Bruce M Psaty; Pui-Yan Kwok
Journal:  Am J Hum Genet       Date:  2005-01-19       Impact factor: 11.025

2.  The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia.

Authors:  Jonathan Pimm; Andrew McQuillin; Srinivasa Thirumalai; Jacob Lawrence; Digby Quested; Nicholas Bass; Graham Lamb; Helen Moorey; Susmita R Datta; Gursharan Kalsi; Allison Badacsonyi; Katie Kelly; Jenny Morgan; Bhaskar Punukollu; David Curtis; Hugh Gurling
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

3.  A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia.

Authors:  Khalid Choudhury; Andrew McQuillin; Vinay Puri; Jonathan Pimm; Susmita Datta; Srinivasa Thirumalai; Robert Krasucki; Jacob Lawrence; Nicholas J Bass; Digby Quested; Caroline Crombie; Gillian Fraser; Nicholas Walker; Haitham Nadeem; Sophie Johnson; David Curtis; David St Clair; Hugh M D Gurling
Journal:  Am J Hum Genet       Date:  2007-03-01       Impact factor: 11.025

4.  Phenotypic variability of patients homozygous for the GJB2 mutation 35delG cannot be explained by the influence of one major modifier gene.

Authors:  Nele Hilgert; Matthew J Huentelman; Ashley Q Thorburn; Erik Fransen; Nele Dieltjens; Malgorzata Mueller-Malesinska; Agnieszka Pollak; Agata Skorka; Jaroslaw Waligora; Rafal Ploski; Pierangela Castorina; Paola Primignani; Umberto Ambrosetti; Alessandra Murgia; Eva Orzan; Arti Pandya; Kathleen Arnos; Virginia Norris; Pavel Seeman; Petr Janousek; Delphine Feldmann; Sandrine Marlin; Françoise Denoyelle; Carla J Nishimura; Andreas Janecke; Doris Nekahm-Heis; Alessandro Martini; Elena Mennucci; Timea Tóth; Istvan Sziklai; Ignacio Del Castillo; Felipe Moreno; Michael B Petersen; Vasiliki Iliadou; Mustafa Tekin; Armagan Incesulu; Ewa Nowakowska; Jerzy Bal; Paul Van de Heyning; Anne-Françoise Roux; Catherine Blanchet; Cyril Goizet; Guenaëlle Lancelot; Graça Fialho; Helena Caria; Xue Zhong Liu; Ouyang Xiaomei; Paul Govaerts; Karen Grønskov; Karianne Hostmark; Klemens Frei; Ingeborg Dhooge; Stephen Vlaeminck; Erdmute Kunstmann; Lut Van Laer; Richard J H Smith; Guy Van Camp
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

5.  Association of bone morphogenetic proteins with otosclerosis.

Authors:  Isabelle Schrauwen; Melissa Thys; Kathleen Vanderstraeten; Erik Fransen; Nele Dieltjens; Jeroen R Huyghe; Megan Ealy; Mireille Claustres; Cor R W J Cremers; Ingeborg Dhooge; Frank Declau; Paul Van de Heyning; Robert Vincent; Thomas Somers; Erwin Offeciers; Richard J H Smith; Guy Van Camp
Journal:  J Bone Miner Res       Date:  2008-04       Impact factor: 6.741

6.  Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment.

Authors:  E Van Eyken; G Van Camp; E Fransen; V Topsakal; J J Hendrickx; K Demeester; P Van de Heyning; E Mäki-Torkko; S Hannula; M Sorri; M Jensen; A Parving; M Bille; M Baur; M Pfister; A Bonaconsa; M Mazzoli; E Orzan; A Espeso; D Stephens; K Verbruggen; J Huyghe; I Dhooge; P Huygen; H Kremer; C W R J Cremers; S Kunst; M Manninen; I Pyykkö; A Lacava; M Steffens; T F Wienker; L Van Laer
Journal:  J Med Genet       Date:  2007-05-18       Impact factor: 6.318

7.  Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia.

Authors:  Nicholas J Bass; Susmita R Datta; Andrew McQuillin; Vinay Puri; Khalid Choudhury; Srinivasa Thirumalai; Jacob Lawrence; Digby Quested; Jonathan Pimm; David Curtis; Hugh Md Gurling
Journal:  Behav Brain Funct       Date:  2009-07-08       Impact factor: 3.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.